Quantifying antiretroviral risk in pregnancy
| dc.contributor.upauthor | Rossouw, Theresa M. | |
| dc.date.accessioned | 2008-06-02T13:17:25Z | |
| dc.date.available | 2008-06-02T13:17:25Z | |
| dc.date.issued | 2007-11 | |
| dc.description.abstract | No abstract available | en |
| dc.format.extent | 93955 bytes | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.citation | Rossouw, T 2007, 'Quantifying antiretroviral risk in pregnancy', South African Medical Journal, vol. 97, no. 11, pp. 1014-1015. [www.samj.org.za ] | en |
| dc.identifier.issn | 0038-3469 | |
| dc.identifier.uri | http://hdl.handle.net/2263/5754 | |
| dc.language.iso | en | en |
| dc.publisher | Health and Medical Publishing Group | en |
| dc.rights | Health and Medical Publishing Group | en |
| dc.subject | Antiretroviral drugs | en |
| dc.subject | Risk factors | en |
| dc.subject | Risks | en |
| dc.subject | Fetal outcome | en |
| dc.subject | Efavirenz | en |
| dc.subject | Pregnancy | en |
| dc.subject | Neural tube defects | en |
| dc.subject | Birth defects | en |
| dc.subject | First trimester | en |
| dc.subject | Highly active antiretroviral therapy (HAART) | en |
| dc.subject | Viral loads | en |
| dc.subject | Obstetric outcome | en |
| dc.subject | Neonatal outcomes | en |
| dc.subject | Statistics | en |
| dc.subject | Treatment Outcome | en |
| dc.subject | Gauteng | en |
| dc.subject.lcsh | Pregnant women | |
| dc.subject.lcsh | HIV-positive women | |
| dc.subject.lcsh | Antiretroviral agents | |
| dc.subject.lcsh | Fetus--Development | |
| dc.subject.lcsh | Newborn infants | |
| dc.title | Quantifying antiretroviral risk in pregnancy | en |
| dc.type | Text | en |